These four stocks are moving on news and gaining technical momentum.
Companies in play in biotech, semiconductor test equipment and software.
Biotech stocks dominate our list of top charts to watch today.
Company chart and information is provided by TradingView based on 15-minute-delayed data.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and others.
| Website: | www.axsome.com |
| Email: | mjacobson@axsome.com |
| Main Phone: | +1 212 332-3241 |
| Address: | 22 Cortlandt Street |
| Address 2: | 16th Floor |
| State: | NY |
| City / Town: | New York |
| Country: | US |
| Postal Code: | 10007 |
| Exchange: | NSD |
| CEO: | Herriot Tabuteau |
| Employees: | 60 |
| NAICS: | Pharmaceutical Preparation Manufacturing(325412) |
These four stocks are moving on news and gaining technical momentum.
Companies in play in biotech, semiconductor test equipment and software.
Biotech stocks dominate our list of top charts to watch today.
AXS-05's novel multimodal mechanism of action is different from all currently marketed antidepressants (Image: Axsome).
| Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
| Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
| Open N/A | High N/A | Low N/A | Prev Close N/A |
| Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
| Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |
© 2022 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
